A Texas federal prosecutor has ordered a major New York hospital system to turn over information about gender-affirming care for minors, widening a cross-state legal campaign over one of the country’s most contested areas of medicine.
The subpoena, sent on 7 May, targets NYU Langone Health and seeks information about minor patients who received such care between 2020 and 2026, according to reports. It also asks for the names of medical providers and others involved in that treatment. NYU Langone said on its website that it was among several institutions that received similar demands, suggesting the request forms part of a broader justice department effort rather than an isolated action.
Key Facts
- A Texas federal prosecutor subpoenaed NYU Langone Health on 7 May.
- The request seeks information on minors who received gender-affirming care from 2020 to 2026.
- The subpoena also asks for the names of providers and others involved in treatment.
- NYU Langone says several institutions received similar subpoenas.
The demand sharpens a growing fight over who controls transgender healthcare for young people: doctors, families, states, or the federal government. By reaching into records held by a hospital network in New York, federal authorities appear to test how far they can extend oversight beyond states that have moved to protect access to this care. Reports indicate the justice department has increasingly tried to track and regulate treatment for trans youth, turning medical systems into front lines in a political and legal struggle.
The subpoena does more than seek records. It raises the stakes for hospitals, providers, and families far from the state where it originated.
What comes next could matter well beyond one hospital system. NYU Langone and other institutions now face decisions about how to respond, what they must disclose, and whether courts will weigh in. For providers, the pressure may reshape how they document and deliver care. For families, it adds new uncertainty to an already fraught landscape. And for policymakers, this latest move could become a test case for how aggressively federal authorities pursue oversight of gender-affirming care for minors across state lines.